An efficient new cannabinoid antiemetic in pediatric oncology.
Life Sci
; 56(23-24): 2097-102, 1995.
Article
em En
| MEDLINE
| ID: mdl-7776837
ABSTRACT
Delta-8-tetrahydrocannabinol (delta-8-THC), a cannabinoid with lower psychotropic potency than the main Cannabis constituent, delta-9-tetrahydrocannabinol (delta-9-THC), was administered (18 mg/m2 in edible oil, p.o.) to eight children, aged 3-13 years with various hematologic cancers, treated with different antineoplastic drugs for up to 8 months. The total number of treatments with delta-8-THC so far is 480. The THC treatment started two hours before each antineoplastic treatment and was continued every 6 hrs for 24 hours. Vomiting was completely prevented. The side effects observed were negligible.
Buscar no Google
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Plantas_medicinales
Assunto principal:
Dronabinol
/
Doença de Hodgkin
/
Linfoma de Burkitt
/
Tumor de Wilms
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
Antieméticos
Idioma:
En
Revista:
Life Sci
Ano de publicação:
1995
Tipo de documento:
Article
País de afiliação:
Israel